ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraakEnglish 
    • EnglishEnglish
    • norsknorsk
  • Administration/UB
View Item 
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • View Item
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants

Permanent link
https://hdl.handle.net/10037/17451
DOI
https://doi.org/10.1111/acps.13104
Thumbnail
View/Open
article.pdf (853.7Kb)
Accepted manuscript version (PDF)
Date
2019-09-27
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
Rognli, Eline Borger; Bramness, Jørgen Gustav; von Soest, Tilmann
Abstract
Objective - Cannabis is an acknowledged risk factor for some mental disorders, but for others the evidence is inconclusive. Prescribed medicinal drugs can be used as proxies for mental disorders. In this study, we investigate how use of cannabis is prospectively related to prescription of antipsychotics, mood stabilizers, antidepressants, and anxiolytics.

Methods - Data on cannabis exposure and relevant confounders were obtained from 2,602 individuals in the longitudinal Young in Norway Study, providing survey data from four data collection waves between 1992 and 2006. Data were coupled with information about prescriptions for psychotropic drugs from the Norwegian Prescription Database between 2007 and 2015.

Results - Past year cannabis use increased the risk of prescription of antipsychotics (OR = 5.56, 95 % CI 1.64 – 18.87), mood stabilizers (OR = 5.36, 95 % CI 1.99 – 14.44) and antidepressants (OR = 2.10, 95 % CI 1.36 – 3.25), after accounting for sociodemographic variables, conduct problems, additional drug use, mental distress, and prescriptions the year before cannabis use was measured.

Conclusions - In this study of young adults from the general population, past year cannabis use was associated with later prescriptions of antipsychotics, mood stabilizers, and antidepressants.

Description
This is the peer reviewed version of the following article: Rognli, E.B., Bramness, J.G. & von Soest, T. (2019). Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants. Acta Phsychiatrica Scandinavica, 141(2), 149-156, which has been published in final form at https://doi.org/10.1111/acps.13104. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Publisher
Wiley
Citation
Rognli EB, Bramness JG, von Soest TvS. Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants. Acta Psychiatrica Scandinavica. 2019:1-8
Metadata
Show full item record
Collections
  • Artikler, rapporter og annet (klinisk medisin) [1974]
©2019 John Wiley & Sons A/S.

Browse

Browse all of MuninCommunities & CollectionsAuthor listTitlesBy Issue DateBrowse this CollectionAuthor listTitlesBy Issue Date
Login

Statistics

View Usage Statistics
UiT

Munin is powered by DSpace

UiT The Arctic University of Norway
The University Library
uit.no/ub - munin@ub.uit.no

Accessibility statement (Norwegian only)